CND Life Sciences funding backs earlier Parkinson’s detection

Growth financing will help expand the Syn-One Test as investors place bigger bets on precision neurology and the future of earlier diagnosis. One of the biggest frustrations in neurology is that by the time diseases such as Parkinson’s become obvious, they have often been quietly progressing for years. The tremors, stiffness and movement problems people […] The post CND Life Sciences funding backs earlier Parkinson’s detection appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.